Department of Dermatology

Antigen targeting of Fc receptors induces strong and functional relevant T cell responses in vivo independent of ITAM signaling but dependent on dendritic cell subsets (2019) Lehmann C, Baranska A, Heidkamp GF, Amon L, Seeling M, Soulat D, Krug AB, et al. Conference contribution Induction of anti-tumor responses via antigen targeting of dendritic cells in vivo (2019) Amon L, Lehmann C, Baranska A, Heidkamp GF, Heger L, Lühr J, Hofmann A, et al. Conference contribution Skin and Soft Tissue Infections Caused by Mycobacterium chelonae: More Common Than Expected? (2019) Uslu U, Boehm O, Heppt F, Sticherling M Journal article Prediction of melanoma evolution in melanocytic nevi via artificial intelligence: A call for prospective data (2019) Sondermann W, Utikal JS, Enk AH, Schadendorf D, Klode J, Hauschild A, Weichenthal M, et al. Journal article Zielgerichtete Therapie bei BRAF-mutiertem metastasierten papillären Schilddrüsenkarzinom und malignen Melanom (2019) Bender-Säbelkampf S, Tüting T, Alter M, Horbrügger M Conference contribution, Abstract of a poster Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. (2019) Wiesinger M, Maerz J, Kummer M, Schuler G, Dörrie J, Schuler-Thurner B, Schaft N Journal article Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Lipase Elevations and Diabetes under Checkpoint Inhibition - Experience in 80 Patients (2019) Weihkopf D, Satzger I, Zimmer L, Eigentler T, Haessel J, Heinzerling L, Herbst R, et al. Conference contribution Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution